news
Scientists have designed a high affinity antibody for pathogenic amyloid…
27 May 2020 | By Hannah Balfour (Drug Target Review)
Scientists have designed a high affinity antibody for pathogenic amyloid beta oligomers, a key driver of Alzheimer’s disease, for use in further research and as a potential diagnostic tool.